SRC activity serves as an essential mediator for cross talk among tyrosine kinase receptors including EGFR and MET [14,20,25], and SRC family kinases have become an attractive and promising target for CRC therapy [17]. The gene discussed is SRC; the disease is colorectal carcinoma.